More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More

Update: 2023-07-12

Description

<span data-sheets-value= "{"1":2,"2":"

This week, we’ll focus further on studies presented at the 2020 ASH Annual Meeting & Exposition, including findings on the use of whole-genome sequencing to trace the origins of a blood cancer; stem cell transplant for older patients with myelodysplastic syndromes; and a triplet therapy for relapsed and refractory multiple myeloma.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we’ll focus further on studies presented at the 2020 ASH Annual Meeting & Exposition, including findings on the use of whole-genome sequencing to trace the origins of a blood cancer; stem cell transplant for older patients with myelodysplastic syndromes; and a triplet therapy for relapsed and refractory multiple myeloma.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

IASLC WCLC 2020: Research in Mesothelioma, Small Cell Lung Cancer, and Drug Development

2023-07-1214:10

IASLC WCLC 2020: Updates From the ADAURA Trial and More

2023-07-1216:22

Prevalence of KRAS G12C Mutations Across Different Populations

2023-07-1213:43

More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer

2023-07-1215:01

Findings From the 2021 Gastrointestinal Cancers Symposium

2023-07-1213:23

IDEA Collaboration: 3 vs 6 Months of Adjuvant Chemotherapy for Patients With Advanced Colon Cancer

2023-07-1212:03

News From the 2020 San Antonio Breast Cancer Symposium

2023-07-1214:45

More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More

2023-07-1212:42

News From the 2020 ASH Annual Meeting & Exposition

2023-07-1215:42

COVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials

2023-07-1210:29

Immune-Related Adverse Events and Survival Outcomes in NSCLC

2023-07-1210:31

Prostate Cancer Highlights From the 2020 ASTRO Annual Meeting

2023-07-1216:10

2020 ASTRO Annual Meeting: High-Impact Research

2023-07-1210:27

Recent FDA Approvals in Leukemia and Lymphoma

2023-07-1215:42

First-Line Atezolizumab vs Chemotherapy for PD-L1–Positive Metastatic NSCLC

2023-07-1212:59

Breast Cancer News From the ESMO Virtual Congress 2020

2023-07-1215:12

Lung Cancer Reports From the ESMO Virtual Congress 2020

2023-07-1212:55

ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers

2023-07-1213:31

ESMO Virtual Congress 2020: Findings in Breast and Head and Neck Cancers

2023-07-1210:26

Veliparib Plus Carboplatin/Paclitaxel in BRCA-Mutated, HER2-Negative Advanced Breast Cancer

2023-07-1214:44

00:00

More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More

#box-pro-ellipsis-173242290996855{-webkit-line-clamp:2;}More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More

More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More

The ASCO Post

More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More